Needham & Company LLC reaffirmed their buy rating on shares of G1 Therapeutics (NASDAQ:GTHX – Free Report) in a report published on Wednesday, Benzinga reports. They currently have a $14.00 target price on the stock. GTHX has been the topic of a number of other reports. Wedbush reissued an outperform rating and issued a $5.00 […]
G1 Therapeutics (NASDAQ:GTHX) Stock Rating Reaffirmed by Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Analysts expect that G1 Therapeutics, Inc. (NASDAQ:GTHX – Get Rating) will post $6.35 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for G1 Therapeutics’ earnings, with the highest sales estimate coming in at $8.00 million and the lowest estimate coming in at $5.60 million. G1 Therapeutics […]
Equities research analysts forecast that G1 Therapeutics, Inc. (NASDAQ:GTHX – Get Rating) will report $6.35 million in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for G1 Therapeutics’ earnings, with the lowest sales estimate coming in at $5.60 million and the highest estimate coming in at $8.00 […]